Animalcare Group (ANCR) Competitors

GBX 231
+1.00 (+0.43%)
(As of 05/10/2024 ET)

ANCR vs. APH, AGY, BXP, EAH, CEL, VLG, BMK, 4BB, EKF, and CREO

Should you be buying Animalcare Group stock or one of its competitors? The main competitors of Animalcare Group include Alliance Pharma (APH), Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), ECO Animal Health Group (EAH), Celadon Pharmaceuticals (CEL), Venture Life Group (VLG), Benchmark (BMK), 4basebio (4BB), EKF Diagnostics (EKF), and Creo Medical Group (CREO). These companies are all part of the "medical" sector.

Animalcare Group vs.

Alliance Pharma (LON:APH) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership, community ranking and analyst recommendations.

Alliance Pharma received 49 more outperform votes than Animalcare Group when rated by MarketBeat users. However, 69.37% of users gave Animalcare Group an outperform vote while only 62.08% of users gave Alliance Pharma an outperform vote.

CompanyUnderperformOutperform
Alliance PharmaOutperform Votes
203
62.08%
Underperform Votes
124
37.92%
Animalcare GroupOutperform Votes
154
69.37%
Underperform Votes
68
30.63%

Alliance Pharma currently has a consensus target price of GBX 80.75, suggesting a potential upside of 131.04%. Given Animalcare Group's higher probable upside, equities analysts clearly believe Alliance Pharma is more favorable than Animalcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alliance Pharma
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Animalcare Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

66.7% of Alliance Pharma shares are owned by institutional investors. Comparatively, 49.3% of Animalcare Group shares are owned by institutional investors. 11.8% of Alliance Pharma shares are owned by insiders. Comparatively, 29.7% of Animalcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Animalcare Group has lower revenue, but higher earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alliance Pharma£170.05M1.11-£7.06M-£0.01-3,495.00
Animalcare Group£74.35M1.87£1.20M£0.0211,550.00

Animalcare Group has a net margin of 1.61% compared to Animalcare Group's net margin of -4.15%. Alliance Pharma's return on equity of 1.53% beat Animalcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Alliance Pharma-4.15% -2.46% 2.99%
Animalcare Group 1.61%1.53%2.67%

In the previous week, Alliance Pharma had 3 more articles in the media than Animalcare Group. MarketBeat recorded 3 mentions for Alliance Pharma and 0 mentions for Animalcare Group. Animalcare Group's average media sentiment score of 0.25 beat Alliance Pharma's score of 0.00 indicating that Alliance Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Alliance Pharma Neutral
Animalcare Group Neutral

Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 5.7%. Animalcare Group pays an annual dividend of GBX 5 per share and has a dividend yield of 2.2%. Alliance Pharma pays out -20,000.0% of its earnings in the form of a dividend. Animalcare Group pays out 25,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.

Alliance Pharma has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Comparatively, Animalcare Group has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.

Summary

Alliance Pharma beats Animalcare Group on 11 of the 19 factors compared between the two stocks.

Get Animalcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ANCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANCR vs. The Competition

MetricAnimalcare GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£138.85M£1.12B£5.12B£1.74B
Dividend Yield2.12%2.99%37.82%7.69%
P/E Ratio11,550.00540.25124.271,996.49
Price / Sales1.8710,056.522,432.89426,049.90
Price / Cash26.0510.0048.3735.45
Price / Book1.787.495.332.74
Net Income£1.20M£153.21M£106.53M£182.20M
7 Day Performance-2.12%-0.65%-0.89%1.37%
1 Month Performance7.44%-0.74%-1.39%3.15%
1 Year Performance19.07%30.61%4.65%10.56%

Animalcare Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APH
Alliance Pharma
2.9707 of 5 stars
GBX 27
-15.6%
GBX 80.75
+199.1%
-47.4%£145.91M£170.05M-2,700.00285News Coverage
Gap Down
High Trading Volume
AGY
Allergy Therapeutics
0 of 5 stars
GBX 3.14
+0.6%
N/A-49.6%£149.78M£53.26M-52.33612News Coverage
High Trading Volume
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 37.50
-1.3%
N/A+4.0%£167.29M£41.65B468.755,700Gap Down
EAH
ECO Animal Health Group
0 of 5 stars
GBX 118.80
+5.6%
N/A-2.1%£80.48M£88.46M-5,940.00234Analyst Forecast
News Coverage
Gap Up
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 98.21
-3.2%
GBX 222.50
+126.6%
-26.8%£63.06M£11,258.00-755.4624News Coverage
Gap Down
VLG
Venture Life Group
0 of 5 stars
GBX 41.43
+2.3%
N/A-2.8%£52.40M£48.57M-4,142.50153
BMK
Benchmark
0 of 5 stars
GBX 44.53
-1.0%
N/A+4.3%£329.34M£155.53M-1,484.40823
4BB
4basebio
0 of 5 stars
GBX 1,090
+0.9%
N/A+95.0%£139.63M£311,000.00-2,137.2578
EKF
EKF Diagnostics
0 of 5 stars
GBX 28.83
-0.6%
N/A+15.4%£130.79M£52.61M2,882.50356
CREO
Creo Medical Group
0 of 5 stars
GBX 34.50
-0.7%
N/AN/A£124.71M£29.27M-313.64279

Related Companies and Tools

This page (LON:ANCR) was last updated on 5/12/2024 by MarketBeat.com Staff

From Our Partners